The impact of using gonadotropin-releasing hormone agonist for triggering final oocyte maturation in antagonist-treated intracytoplasmic sperm injection cycles on women at high risk of developing ovarian hyperstimulation syndrome

Releasing Hormone ◽

Final Oocyte Maturation ◽

The Impact

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting

10.1016/j.fertnstert.2009.10.034 ◽

2010 ◽

Vol 94 (3) ◽

pp. 1111-1114 ◽

Cited By ~ 29

Author(s):

Andrea J. DiLuigi ◽

Lawrence Engmann ◽

David W. Schmidt ◽

Donald B. Maier ◽

John C. Nulsen ◽

...

Keyword(s):

High Risk ◽

Clinical Outcomes ◽

Oocyte Maturation ◽

Releasing Hormone ◽

Final Oocyte Maturation ◽

Risk Patients

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a “freeze-all” strategy: a prospective multicentric study

10.1016/j.fertnstert.2011.01.163 ◽

2011 ◽

Vol 95 (6) ◽

pp. 2029-2033.e1 ◽

Cited By ~ 105

Author(s):

Georg Griesinger ◽

Laura Schultz ◽

Thomas Bauer ◽

Anke Broessner ◽

Thorsten Frambach ◽

...

Keyword(s):

Oocyte Maturation ◽

Multicentric Study ◽

Releasing Hormone ◽

Final Oocyte Maturation ◽

Antagonist Protocol

Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study

10.1016/j.fertnstert.2009.08.036 ◽

2010 ◽

Vol 93 (7) ◽

pp. 2418-2420 ◽

Cited By ~ 36

Author(s):

Daniel Bodri ◽

Juan José Guillén ◽

Marta Trullenque ◽

Katja Schwenn ◽

Carolina Esteve ◽

...

Keyword(s):

High Risk ◽

Luteal Phase ◽

Releasing Hormone ◽

Oocyte Donor ◽

Follow Up Study

Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology?

Journal of Clinical Medicine Research ◽

10.14740/jocmr2500w ◽

2016 ◽

Vol 8 (5) ◽

pp. 396-401 ◽

Cited By ~ 3

Author(s):

Ali Sami Gurbuz ◽

Ruya Deveer ◽

Mert Kucuk ◽

Necati Ozcimen ◽

Dilek Incesu ◽

...

Keyword(s):

Luteal Support ◽

Releasing Hormone ◽

Ovarian Morphology

Gonadotropin-releasing hormone agonist (GnRH-a) triggering may improve live birth rates and reduce ovarian hyperstimulation syndrome (OHSS) in 'freeze-all' cycles: time to re-think conventional triggering?

10.1016/j.fertnstert.2017.07.716 ◽

2017 ◽

Vol 108 (3) ◽

pp. e238

Author(s):

M.J. Davenport ◽

K. Sorby ◽

T. Osianlis ◽

V.B. MacLachlan ◽

B.J. Vollenhoven ◽

...

Keyword(s):

Live Birth ◽

Gonadotropin Releasing Hormone Agonist

Birth Rates ◽

Releasing Hormone ◽

Live Birth Rates ◽

Final Oocyte Maturation in Assisted Reproduction with Human Chorionic Gonadotropin and Gonadotropin-releasing Hormone agonist (Dual Trigger)

JBRA Assisted Reproduction ◽

10.5935/1518-0557.20160047 ◽

2016 ◽

Vol 20 (4) ◽

pp. 246-250 ◽

Cited By ~ 10

Author(s):

Sofia Andrade de Oliveira ◽

Vinícius Fernando Calsavara ◽

Gemma Castillón Cortés

Keyword(s):

Assisted Reproduction ◽

Oocyte Maturation ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Releasing Hormone ◽

Final Oocyte Maturation

Ovarian Hyperstimulation Syndrome Prevention Strategies: Oral Contraceptive Pills-Dual Gonadotropin-Releasing Hormone Agonist Suppression with Step-Down Gonadotropin Protocols

Seminars in Reproductive Medicine ◽

10.1055/s-0030-1265673 ◽

2010 ◽

Vol 28 (06) ◽

pp. 468-474 ◽

Cited By ~ 2

Author(s):

Mark Damario

Keyword(s):

Oral Contraceptive ◽

Prevention Strategies ◽

Oral Contraceptive Pills ◽

Releasing Hormone ◽

Contraceptive Pills ◽

Step Down

Variations in l-selectin ligand expression in the luteal-phase endometrium after final oocyte maturation with human chorionic gonadotropin compared with a gonadotropin-releasing hormone agonist

10.1016/j.fertnstert.2007.06.075 ◽

2008 ◽

Vol 90 (3) ◽

pp. 876-878 ◽

Cited By ~ 1

Author(s):

C LIPARI ◽

Y ZHAO ◽

J KING ◽

C ALEXANDER ◽

B BANKOWSKI ◽

...

Keyword(s):

Oocyte Maturation ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Luteal Phase ◽

Releasing Hormone ◽

Final Oocyte Maturation ◽

Ligand Expression ◽

Selectin Ligand

Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and “freeze-all”: in-depth analysis of genetic predisposition

Journal of Assisted Reproduction and Genetics ◽

10.1007/s10815-015-0498-y ◽

2015 ◽

Vol 32 (7) ◽

pp. 1063-1068 ◽

Cited By ~ 19

Author(s):

Samuel Santos-Ribeiro ◽

Nikolaos P. Polyzos ◽

Katrien Stouffs ◽

Michel De Vos ◽

Sara Seneca ◽

...

Keyword(s):

Genetic Predisposition ◽

Releasing Hormone ◽

Depth Analysis

A comparison of gonadotropin releasing hormone agonist (gnrha) and human chorionic gonadotropin (hCG) for final oocyte maturation in an egg donor population

10.1016/j.fertnstert.2013.07.1107 ◽

2013 ◽

Vol 100 (3) ◽

pp. S264

Author(s):

S.J. Morin ◽

D.H. McCulloh ◽

F. Licciardi

Keyword(s):

Oocyte Maturation ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Releasing Hormone ◽

Final Oocyte Maturation ◽

Egg Donor ◽

Donor Population